Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	147.42	77.14	31.18
Graham Fair Price	-47.60	5659.92	10801.57
PEG	569.12	-0.26	0.04
Price/Book	-7.59	1.16	1.26
Price/Cash Flow	368.20	-112.53	24.03
Prices/Earnings	237.38	32.68	-9.69
Price/Sales	22.85	3.37	2.74
Price/FCF	368.20	-112.53	24.03
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	2.38	0.54	0.52
Operating Margin	-60.13	0.04	0.09
ROA	-73.28	< 0.005	-0.02
ROE	-0.03	< 0.005	-72.61
ROIC	0.02	< 0.005	-67.07
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.08	-0.08	-5.35
Dividends QOQ	-0.72	403.49	56052.21
EBIT QOQ	0.20	-0.70	256.03
EPS QOQ	-2.53	1.27	-49.58
FCF QOQ	1.45	-1.20	-17.16
Revenue QOQ	0.04	-0.25	591.07
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	111.88	169.81	51.78
Days Sales Outstanding (DSO)	59.59	77.38	29.86
Inventory Turnover	0.80	0.53	-34.12
Debt/Capitalization	0.27	0.29	5.42
Quick Ratio	0.51	0.48	-6.04
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	12628.51	12643.80	0.12
Cash	1052.11	1262.89	20.03
Capex	-277.30	-278.15	-0.31
Free Cash Flow	661.98	-130.81	-80.24
Revenue	5799.42	4367.49	-24.69
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.94	0.88	-6.03
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	6.52	17.44	167.26
Naive Interpretation	Member

06 - Financial Health · Bad

Rating